REGENXBIO Inc. Shares Jump After for A Potential Eye Care Treatment
REGENXBIO Inc. (NASDAQ: RGNX) stock surged more than 20% on Monday after the clinical-stage biotechnology company announced a partnership to develop and commercialize RGX-314, a potential one-time gene therapy for the treatment of wet age-related macular degeneration (wet AMD), diabetic...